ACEIs and ARBs may Reduce risk of Ventilator-Associated Pneumonia in High-Risk ICU Patients: Study Dr. Shravani Dali3 Dec 2024 8:15 PM ISTA study published in BMC Pulmonary Medicine suggests that ACEIs and ARBs may Reduce the risk of Ventilator-Associated Pneumonia in High-Risk ICU...
Combination therapy with ARBs and Beta-blockers for post-PCI patients with hypertension-Expert Opinion of Indian Cardiologists Dr Jeegar Dattani4 Jun 2024 11:00 AM ISTThe expert opinion is the first of its kind, guiding Indian Cardiologists in managing hypertension in post-PCI patients with comorbidities. A total of...
Discontinuing RAS inhibitors in advanced CKD doesn't slow decline in estimated GFR: NEJM Dr.Niharika Harsha B7 Nov 2022 8:00 PM ISTA new study found that discontinuation of Renin-angiotensin inhibitors in progressive and advanced end-stage kidney disease patients is not linked to...
Combination of ARBs and beta blockers may delay need for surgery in patients with Marfan syndrome Dr. Kamal Kant Kohli6 Sept 2022 9:00 AM ISTAccording to new patient-level meta-analysis both angiotensin receptor blockers (ARBs) as well as beta-blockers reduce the rate of aortic enlargement...
Hypertension among COVID-19 patients associated with poor prognosis, finds study Dr.Niharika Harsha B21 Aug 2022 8:00 PM ISTA new investigation revealed that in-hospital mortality and adverse outcomes in COVID-19 are due to hypertension, but angiotensin-converting enzyme...
Zinc complexation may improve antihypertensive effect of Telmisartan: Study MD Bureau12 March 2021 10:15 AM ISTAngiotensin II receptor blockers were designed as therapeutic agents to block the binding site of the angiotensin II receptor type 1 (AT1R). A recent...
Managing Difficult to Treat Hypertension with Newer ARBs Prof. Soumitra Kumar18 July 2020 12:15 PM ISTA considerable number of patients with hypertension remain resistant to treatment despite the many therapeutic options available today for...
Captopril linked to more pulmonary events in COVID 19 affected Diabetics Dr.Niharika Harsha B7 July 2020 12:30 PM ISTCaptopril has been found to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE...
High BP drugs may reduce risk of colorectal cancer: AHA Journal Hina Zahid6 July 2020 12:45 PM ISTDALLAS --Colorectal cancer is the third most common cancer and is the second leading cause of cancer death worldwide.Researchers have found that...
ACEIs and ARBs may improve prognosis of high BP patients with COVID-19, finds review Dr. Kamal Kant Kohli31 March 2020 8:24 AM ISTRochester, MN, - Researchers after reviewing studies have concluded that ACEIs and ARBs, may have a role to play in the treatment of COVID-19 and may...
COVID-19 patients not to stop ACE Inhibitors & ARB's, recommend Heart Groups Dr. Kamal Kant Kohli18 March 2020 11:30 AM ISTAmerican Heart Association, the American College of Cardiology, and the Heart Failure Society of America have issued a joint statement urging...
